Skip to main content

Advertisement

Log in

Autoantibodies to desmogleins 1 and 3 in patients with lichen planus

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

An Erratum to this article was published on 08 August 2017

This article has been updated

Abstract

There is controversy about the role of autoantibodies against desmoglein 1 and 3 (Dsg1 and 3) in the pathogenesis of lichen planus (LP); the authors planned this study to determine the presence of circulating levels of these antibodies in patients with different types of oral LP and to compare that with cutaneous LP and healthy controls. The enzyme-linked immunosorbent assay test was performed on serum samples of 24 cases of erosive oral LP, 29 cases of reticular oral LP, 30 cases of cutaneous LP and 30 healthy controls. The severity of oral LP was evaluated by Reticulation, Erosion and Ulceration scoring system. There were no significant differences in the concentrations of autoantibodies to Dsg1 between the four groups. Autoantibodies to Dsg3 were increased in erosive oral LP compared with healthy controls (p value = 0.005) but no increase was observed between other groups. We did not detect a correlation between the severity of the disease and the levels of anti-Dsg1 and 3 in patients with erosive and reticular types of oral LP. In conclusion, regardless of the increased level of anti-Dsg3 antibody in erosive oral LP, serum concentrations of antibodies were under cut-off values. Moreover, the pathogenic role of anti-Dsg3 antibodies in erosive oral LP is uncertain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Change history

  • 08 August 2017

    An erratum to this article has been published.

References

  1. Agarwal R, Saraswat A (2002) Oral lichen planus: an update. Drugs Today (Barc) 38(8):533–547

    Article  Google Scholar 

  2. Chainani-Wu N, Silverman S Jr, Reingold A, Bostrom A, Lozada-Nur F, Weintraub J (2008) Validation of instruments to measure the symptoms and signs of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105(1):51–58. doi:10.1016/j.tripleo.2007.06.022

    Article  PubMed  Google Scholar 

  3. D’Agosto G, Latini A, Carducci M, Mastroianni A, Vento A, Fei PC (2004) Evaluation of recombinant antigen-based assays for diagnosis of bullous autoimmune diseases. Clin Diagn Lab Immunol 11(4):762–765. doi:10.1128/CDLI.11.4.762-765.2004

    PubMed  PubMed Central  Google Scholar 

  4. Eversole LR (1997) Immunopathogenesis of oral lichen planus and recurrent aphthous stomatitis. Semin Cutan Med Surg 16(4):284–294

    Article  CAS  PubMed  Google Scholar 

  5. Gholizadeh N, Khoini Poorfar H, TaghaviZenouz A, Vatandoost M, Mehdipour M (2015) Comparison of serum autoantibodies to desmogleins I, III in patients with oral lichen planus and healthy controls. Iran J Pathol 10(2):136–140

    PubMed  PubMed Central  Google Scholar 

  6. Harman KE, Seed PT, Gratian MJ, Bhogal BS, Challacombe SJ, Black MM (2001) The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol 144(4):775–780

    Article  CAS  PubMed  Google Scholar 

  7. Herrero-González JE, Parera Amer E, Segura S, Mas Bosch V, Pujol RM, Martínez Escala ME (2016) Epithelial antigenic specificities of circulating autoantibodies in mucosal lichen planus. Int J Dermatol 55(6):634–639. doi:10.1111/ijd.12990

    Article  PubMed  Google Scholar 

  8. Ingafou M, Lodi G, Olsen I, Porter SR (1997) Oral lichen planus is not associated with IgG circulating antibodies to epithelial antigens. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84(2):175–178

    Article  CAS  PubMed  Google Scholar 

  9. Jamora MJ, Jiao D, Bystryn JC (2003) Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris. J Am Acad Dermatol 48(6):976–977. doi:10.1067/mjd.20030438

    Article  PubMed  Google Scholar 

  10. Kamiya K, Aoyama Y, Shirafuji Y, Hamada T, Morizane S, Fujii K, Hisata K, Iwatsuki K (2012) Detection of antibodies against the non-calcium-dependent epitopes of desmoglein 3 in pemphigus vulgaris and their pathogenic significance. Br J Dermatol 167(2):252–261. doi:10.1111/j.1365-2133.2012.10929.x

    Article  CAS  PubMed  Google Scholar 

  11. Kato T, Fujimoto N, Uenishi T, Tanaka T (2009) A case of oral lichen planus in a patient with anti-desmoglein antibodies. Skin Res 8:173–176

    Google Scholar 

  12. Kinjyo C, Kaneko T, Korekawa A, Rokunohe A, Aizu T, Matsuzaki Y, Nakano H, Sawamura D (2015) Oral lichen planus with antibodies to desmogleins 1 and 3. J Dermatol 42(1):40–41. doi:10.1111/1346-8138.12661

    Article  CAS  PubMed  Google Scholar 

  13. Kishimoto K, Konno Y, Nakamura K, Kaneko F (2005) A case of oral lichen planus showing antibodies for desmoglein 1 and BP180 NC16a. Rinsho Derma 47:741–744

    Google Scholar 

  14. Lamey PJ, McCartan BE, MacDonald DG, MacKie RM (1995) Basal cell cytoplasmic autoantibodies in oral lichenoid reactions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79(1):44–49

    Article  CAS  PubMed  Google Scholar 

  15. Lin SC, Sun A, Wu YC, Chiang CP (1992) Presence of anti-basal cell antibodies in oral lichen planus. J Am Acad Dermatol 26(6):943–947

    Article  CAS  PubMed  Google Scholar 

  16. Lukac J, Brozović S, Vucicević-Boras V, Mravak-Stipetić M, Malenica B, Kusić Z (2006) Serum autoantibodies to desmogleins 1 and 3 in patients with oral lichen planus. Croat Med J 47(1):53–58

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Mutasim DF, Adams BB (2001) Immunofluorescence in dermatology. J Am Acad Dermatol 45(6):803–822. doi:10.1067/mjd.2001.117518 (quiz 822–4)

    Article  CAS  PubMed  Google Scholar 

  18. Muramatsu K, Nishie W, Natsuga K, Fujita Y, Iwata H, Yamada T, Yamashita E, Asaka T, Shimizu H (2016) Two cases of erosive oral lichen planus with autoantibodies to desmoglein 3. J Dermatol 43(11):1350–1353. doi:10.1111/1346-8138.13493

    Article  PubMed  Google Scholar 

  19. Park HK, Hurwitz S, Woo SB (2012) Oral lichen planus: REU scoring system correlates with pain. Oral Surg Oral Med Oral Pathol Oral Radiol 114(1):75–82. doi:10.1016/j.oooo.2012.02.013

    Article  PubMed  Google Scholar 

  20. Piboonniyom SO, Treister N, Pitiphat W, Woo SB (2005) Scoring system for monitoring oral lichenoid lesions: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99(6):696–703. doi:10.1016/j.tripleo.2004.07.013

    Article  PubMed  Google Scholar 

  21. Schiødt M, Holmstrup P, Dabelsteen E, Ullman S (1981) Deposits of immunoglobulins, complement, and fibrinogen in oral lupus erythematosus, lichen planus, and leukoplakia. Oral Surg Oral Med Oral Pathol 51(6):603–608

    Article  PubMed  Google Scholar 

  22. Shiohara T, Kano Y, Jean L (2012) Lichen planus and lichenoid dermatoses. In: Bolognia JL, Jorizzo JL, Schaffer JV (eds) Dermathology, 3rd edn. Saunders/Elsevier, New York, p 192

    Google Scholar 

  23. Shipman AR, Cooper S, Wojnarowska F (2011) Autoreactivity to bullous pemphigoid 180: is this the link between subepidermal blistering diseases and oral lichen planus? Clin Exp Dermatol 36(3):267–269. doi:10.1111/j.1365-2230.2010.03878.x

    Article  CAS  PubMed  Google Scholar 

  24. Shirakata Y, Amagai M, Hanakawa Y, Nishikawa T, Hashimoto K (1998) Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1. J Invest Dermatol 110(1):76–78. doi:10.1046/j.1523-1747.1998.00085.x

    Article  CAS  PubMed  Google Scholar 

  25. Stanley JR (1989) Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. J Clin Invest 83(5):1443–1448. doi:10.1172/JCI114036

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, Zhou XJ, Khan A, Seymour GJ, Bigby M (2002) The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 13(4):350–365

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by Tehran University of Medical Sciences and Health Services. We thank our colleagues in Razi Hospital, especially Dr. Maryam Daneshpazhooh for comments that improved the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ghaedi Forugh.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Funding

This study was funded by Tehran University of Medical Sciences.

Ethical statement

The study was approved by the Ethics Committee of Tehran University of Medical Sciences.

Informed consent

Informed consent was obtained from each subject.

Additional information

An erratum to this article is available at https://doi.org/10.1007/s00403-017-1766-8.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vahide, L., Zahra, H., Forugh, G. et al. Autoantibodies to desmogleins 1 and 3 in patients with lichen planus. Arch Dermatol Res 309, 579–583 (2017). https://doi.org/10.1007/s00403-017-1756-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-017-1756-x

Keywords

Navigation